Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study.
COVID-19
MRSA
Staphylococcus aureus
ceftaroline
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
23 Jun 2021
23 Jun 2021
Historique:
received:
04
06
2021
revised:
15
06
2021
accepted:
21
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
A single-center cross-sectional study was conducted to describe the use of ceftaroline in a large teaching hospital in Northern Italy, during a period also including the first months of the coronavirus disease 2019 (COVID-19) pandemic. The primary objective was to describe the use of ceftaroline in terms of indications and characteristics of patients. A secondary objective was to describe the rate of favorable clinical response in patients with bloodstream infections (BSI) due to methicillin-resistant
Identifiants
pubmed: 34201722
pii: antibiotics10070763
doi: 10.3390/antibiotics10070763
pmc: PMC8300614
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Pfizer
ID : WI242147
Références
Infect Dis (Lond). 2018 Aug;50(8):643-647
pubmed: 29508663
Clin Ther. 2017 Jan;39(1):212-218
pubmed: 28038791
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858203
Infect Dis (Lond). 2017 May;49(5):410-416
pubmed: 28116950
JAMA. 2020 Feb 11;323(6):527-537
pubmed: 32044943
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2199-2203
pubmed: 32535805
Int J Antimicrob Agents. 2020 Apr;55(4):105921
pubmed: 32061999
Int J Antimicrob Agents. 2021 Apr;57(4):106310
pubmed: 33609718
Ther Adv Infect Dis. 2019 Nov 7;6:2049936119886504
pubmed: 31857898
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
Infect Dis Ther. 2020 Mar;9(1):77-87
pubmed: 31776844
Open Forum Infect Dis. 2019 Dec 31;7(1):ofz538
pubmed: 31938716
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27895012
Ann Pharmacother. 2016 Dec;50(12):1051-1059
pubmed: 27520326
Clin Infect Dis. 2016 Jan 15;62(2):173-180
pubmed: 26349552
Clin Microbiol Infect. 2020 Nov;26(11):1537-1544
pubmed: 32810610
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Clin Ther. 2014 Oct 1;36(10):1317-33
pubmed: 25017183
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32312776